Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Bioptigen Wins $458K Loan for Validation of Intrasurgical OCT System

Mar 2015
MORRISVILLE, N.C. — Bioptigen has been awarded a $458,000 strategic growth loan from the North Carolina Biotechnology Center to support clinical validation of the company’s intrasurgical optical coherence tomography (OCT) imaging system.

The EnFocus system will provide 3-D visualization simultaneous with, and co-registered to, images from surgical ophthalmic microscopes. The device is intended to enable precision surgery with better patient outcomes and reduce the need for postsurgical follow-up procedures.

In September, Bioptigen received grants totaling $1.72 million from the National Eye Institute for development of the technology.

The company’s OCT imaging devices are sold to pediatric and surgical ophthalmology clinics and hospitals, and academic ophthalmology research centers globally.

For more information, visit

The branch of medicine involved in the study of the anatomy, functions, diseases and treatments of the eye.
BusinessBiophotonicsAmericasNorth CarolinaBioptigenOCToptical coherence tomographyophthalmologyRapidScan

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!